Feb 4 (Reuters) - United Therapeutics Corp UTHR.O:
UNITED THERAPEUTICS CORPORATION ANNOUNCES FULL ENROLLMENT OF THE TETON 1 STUDY OF INHALED TREPROSTINIL FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
UNITED THERAPEUTICS CORP - TOP LINE DATA EXPECTED IN FIRST HALF OF 2026
Source text: ID:nBw8RKwQ5a
Further company coverage: UTHR.O